2021 Oct 10.
 doi: 10.1007/s10875-021-01147-8. Online ahead of print.

Genetic Risk Variants for Class Switching Recombination Defects in Ataxia-Telangiectasia Patients

Parisa Amirifar12Mahya Mehrmohamadi3Mohammad Reza Ranjouri2Seyed Mohammad Akrami1Nima Rezaei24Ali Saberi5Reza Yazdani24Hassan Abolhassanihassan.abolhassani@ki.se." href="https://pubmed.ncbi.nlm.nih.gov/34628594/#affiliation-6" ref="linksrc=author_aff" style="box-sizing: inherit; background-color: rgb(241, 241, 241); color: rgb(50, 58, 69); text-decoration: none; font-size: inherit; display: inline-block; line-height: 1; padding: 0.1rem 0.3rem; border-radius: 2px; transition: color 0.3s ease 0s;">6hassan.abolhassani@ki.se." href="https://pubmed.ncbi.nlm.nih.gov/34628594/#affiliation-7" ref="linksrc=author_aff" style="box-sizing: inherit; background-color: rgb(241, 241, 241); color: rgb(50, 58, 69); text-decoration: none; font-size: inherit; display: inline-block; line-height: 1; padding: 0.1rem 0.3rem; border-radius: 2px; transition: color 0.3s ease 0s;">7hassan.abolhassani@ki.se." href="https://pubmed.ncbi.nlm.nih.gov/34628594/#affiliation-8" ref="linksrc=author_aff" style="box-sizing: inherit; background-color: rgb(241, 241, 241); color: rgb(50, 58, 69); text-decoration: none; font-size: inherit; display: inline-block; line-height: 1; padding: 0.1rem 0.3rem; border-radius: 2px; transition: color 0.3s ease 0s; margin-right: 0px;">8Asghar Aghamohammadiaghamohammadi@sina.tums.ac.ir." href="https://pubmed.ncbi.nlm.nih.gov/34628594/#affiliation-9" ref="linksrc=author_aff" style="box-sizing: inherit; background-color: rgb(241, 241, 241); color: rgb(50, 58, 69); text-decoration: none; font-size: inherit; display: inline-block; line-height: 1; padding: 0.1rem 0.3rem; border-radius: 2px; transition: color 0.3s ease 0s;">9aghamohammadi@sina.tums.ac.ir." href="https://pubmed.ncbi.nlm.nih.gov/34628594/#affiliation-10" ref="linksrc=author_aff" style="box-sizing: inherit; background-color: rgb(241, 241, 241); color: rgb(50, 58, 69); text-decoration: none; font-size: inherit; display: inline-block; line-height: 1; padding: 0.1rem 0.3rem; border-radius: 2px; transition: color 0.3s ease 0s; margin-right: 0px;">10
Affiliations 

Affiliations

  • 1Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • 2Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran.
  • 3Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran.
  • 4Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • 5Department of Computer Engineering, Sharif University of Technology, Tehran, Iran.
  • 6Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran. hassan.abolhassani@ki.se.
  • 7Division of Clinical Immunology, Department of Biosciences and Nutrition, NEO, Karolinska Institute, Blickagangen 16, 14157, Stockholm, Sweden. hassan.abolhassani@ki.se.
  • 8Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden. hassan.abolhassani@ki.se.
  • 9Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran. aghamohammadi@sina.tums.ac.ir.
  • 10Children's Medical Center Hospital, 62 Qarib St., Keshavarz Blvd, 14194, Tehran, Iran. aghamohammadi@sina.tums.ac.ir.

Abstract

Background: Ataxia-telangiectasia (A-T) is a rare autosomal recessive disorder caused by mutations in the ataxia telangiectasia mutated (ATM) gene. A-T patients manifest considerable variability in clinical and immunological features, suggesting the presence of genetic modifying factors. A striking heterogeneity has been observed in class switching recombination (CSR) in A-T patients which cannot be explained by the severity of ATM mutations.

Methods: To investigate the cause of variable CSR in A-T patients, we applied whole-exome sequencing (WES) in 20 A-T patients consisting of 10 cases with CSR defect (CSR-D) and 10 controls with normal CSR (CSR-N). Comparative analyses on modifier variants found in the exomes of these two groups of patients were performed.

Results: For the first time, we identified some variants in the exomes of the CSR-D group that were significantly associated with antigen processing and presentation pathway. Moreover, in this group of patients, the variants in four genes involved in DNA double-strand breaks (DSB) repair signaling, in particular, XRCC3 were observed, suggesting an association with CSR defect.

Conclusion: Additional impact of certain variants, along with ATM mutations, may explain the heterogeneity in CSR defect phenotype among A-T patients. It can be concluded that genetic modulators play an important role in the course of A-T disease and its clinical severity.

Keywords: ATM; Ataxia-telangiectasia (A-T); Class switching recombination (CSR); DNA repair; Inborn errors of immunity; Modifier genes; Primary immunodeficiency; Whole-exome sequencing.